Trump to Announce Tariffs on Alternative Medicines
President Donald Trump has made the decision to impose import tariffs on alternative medicines starting in mid-2028, with the aim of encouraging pharmaceutical companies to manufacture them within the United States. These medicines will remain exempt from tariffs until August 2028, after which a 100% tariff will be applied for one year, increasing to 200% thereafter. Companies will be granted a two-year grace period to relocate the production of alternative medicines to the United States, with the possibility of sanctions being imposed on companies that do not comply. The details and the legal basis for these tariffs have not been specified. The move is intended to pressure companies producing medicines outside the U.S. to boost domestic manufacturing.
Notice: This Is an AI-Generated Summary
Comments (0)